| Abl | Successful target | Tyrosine-protein kinase ABL1;Abelson murine leukemia viral oncogene homolog 1;Abelson tyrosine-protein kinase 1;Proto-oncogene c-Abl;p150 | Chronic myeloid leukaemia;Leukemia;Chronic myelogenous leukemia;Cancer;Acute myeloid leukemia;Acute lymphoblastic leukemia;Philadelphia-positive ALL and CML | Imatinib;Imatinib;Imatinib;NPB-001-056;Nilotinib;Radotinib;AN-019;Ponatinib;Dasatinib;Dasatinib;AZD0530;Bafetinib;Bafetinib;Bafetinib;Adaphostin;Adenosine triphosphate;DCC-2036;Flumatinib;Bosutinib;KW-2449;SKI-758;ABL 001 | AG-1879;BAS-0338876;MC-2001;PD-0173956;BAS-00387347;BAS-00387328;BAS-09534324;4,3'',5''-trimethoxy-[1,1':3',1'']-terphenyl;AP-24226;Bis-(5-hydroxy-1H-indol-2-yl)-methanone;Imatinib;NPB-001-056;Nilotinib;[1,1':2',1'']-terphenyl-4,3'',5''-triol;BAS-00672722;BAS-0338872;Radotinib;BAS-00387275;AN-019;TRISMETHOXYRESVERATROL;PD-0173955;Dasatinib;AZD0530;4-[(3,5-diamino-1H-pyrazol-4-yl)diazenyl]phenol;Bafetinib;AP-24163;Adaphostin;Adenosine triphosphate;3'',5''-dimethoxy-[1,1':2',1'']-terphenyl-4-ol;3'',5''-dimethoxy-[1,1':3',1'']-terphenyl-4-ol;MYRISTIC ACID;BAS-01373578;Flumatinib;Bosutinib;SKI-758;ON-044580;(E)-4-(3,5-dimethoxystyryl)phenol;ABL 001;JNJ-10198409;4,3'',5''-trimethoxy-[1,1':2',1'']-terphenyl;TG-100435;PD-0166326 | KW-2449 |